Bourgouin S, Ewald J, Mancini J, Moutardier V, Delpero JR, Le Treut YP. Predictors of survival in ampullary, bile duct and duodenal cancers following pancreaticoduodenectomy: a 10 year multicentre analysis. J Gastrointest Surg. 2015;19(7):1247–55.
Hong SM, Pawlik TM, Cho HJ, Aggarwal B, Goggins M, Hruban RH, et al. Depth of tumor invasion better predicts prognosis than the current American joint committee on cancer T classification for distal bile duct carcinoma. Surgery. 2009;146(2):250–7.
Wellner UF, Shen YF, Keck T, Jin WY, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5 year survival. Surg Today. 2017;47:271–9.
Miura F, Sano K, Wada K, Shibuya M, Ikeda Y, Takahashi K, et al. Prognostic impact of type of preoperative biliary drainage in patients with distal cholangiocarcinoma. Am J Surg. 2017;214:256–61.
Andrianello S, Paiella S, Allegrini V, Ramera M, Pulvirenti A, Malleo G, et al. Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. Langenbeck’s Arch Surg. 2015;400:623–8.
Labib PL, Russell TB, Denson JL, Puckett MA, Ausania F, Pando E, et al. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: an international multicentre retrospective cohort study. Eur J Surg Oncol. 2024;50: 108353. https://doi.org/10.1016/j.ejso.2024.108353.
Xu S, Zhang XP, Zhao GD, Zhao ZM, Gao YX, Hu MG, et al. Development and validation of an online calculator to predict early recurrence and long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2022;29:1214–25.
Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg. 2015;102:399–406.
Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol. 2016;38(Suppl. 1):123–32.
Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105.
Pilling LC, Atkins JL, Kuchel GA, Ferrucci L, Melzer D. Red cell distribution width and common disease onsets in 240,477 healthy volunteers followed for up to 9 years. PLoS ONE. 2018;13(9): e0203504.
PubMed PubMed Central Google Scholar
Katsaros M, Paschos P, Giouleme O. Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review. Ann Gastroenterol. 2020;33:348–54.
PubMed PubMed Central Google Scholar
Koma Y, Onishi A, Matsuoka H, Oda N, Yokota N, Matsumoto Y, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS ONE. 2013;8(11): e80240.
CAS PubMed PubMed Central Google Scholar
Ide S, Toiyama Y, Okugawa Y, Omura Y, Kitajima T, Fujikawa H, et al. Clinical significance of an increased red blood cell distribution width in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Surg Today. 2020;50:551–9.
Smirne C, Grossi G, Pinato DJ, Burlone ME, Mauri FA, Januszewski A, et al. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Dig liver Dis. 2015;47:488–94.
Li B, You Z, Xiong XZ, Zhou Y, Wu SJ, Zhou RX, et al. Elevated red blood cell distribution width predicts poor prognosis in hilar cholangiocarcinoma. Oncotarget. 2017;8(65):109468–77.
PubMed PubMed Central Google Scholar
Dang C, Wang M, Qin T, Qin R. Clinical importance of preoperative red-cell volume distribution width as a prognostic marker in patients undergoing radical surgery for pancreatic cancer. Surg Today. 2022;52:465–74.
Japanese Society of Biliary Surgery. General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract, 7th edn. Tokyo: Kanehara. 2021.
Shimoda M, Kubota K, Katoh M, Kita J. Effect of billroth II or Roux-en-Y reconstruction for the gastrojejunostomy on delayed gastric emptying after pancreaticoduodenectomy: a randomized controlled study. Ann Surg. 2013;257:938–42.
Sobin LH, Gospodarowicz MK, Wittekind C, editors. International union against cancer. UICC TNM classification of malignant tumors. 7th ed. New York: Wiley & Blackwell; 2010.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
PubMed PubMed Central Google Scholar
Ignacio De Ulíbarri J, González-Madrono A, de Villar NG, Gonzalez P, Gonzalez B, Mancha A, Rodriguez F, et al. CONUT: a tool for controlling nutritional status First validation in a hospital population. Nutr Hosp. 2005;20(1):38–45.
Shimizu T, Ishizuka M, Kubota K. A lower neutrophil to lymphocyte ratio is closely associated with catarrhal appendicitis versus severe appendicitis. Surg Today. 2016;46(1):84–9.
Shirai Y, Hamura R, Tanji Y, Taniai T, Yanagaki M, Haruki K, et al. The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer. Surg Today. 2024;54(3):247–57.
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004;90:1704–6.
CAS PubMed PubMed Central Google Scholar
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.
Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133:628–32.
Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37(9):11553–72.
Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158(4):659–66.
McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer. 2001;41:64–60.
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.
Goyal H, Gupta S, Singla U. Level of red cell distribution width is affected by various factors. Clin Chem Lab Med. 2016;54(12): e387.
Terasaki F, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, et al. Use of preoperative controlling nutritional status (CONUT) score as a better prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy. Surg Today. 2021;51(3):358–65.
Zheng Y, Wu F, Rong W, Liu Y, Siqin T, Wang L, et al. Prognostic value of the controlling nutritional status (CONUT) score in intrahepatic cholangiocarcinoma patients especially who had long-time alcohol consumption. J Clin Biochem Nutr. 2020;67(3):323–31.
CAS PubMed PubMed Central Google Scholar
Sato R, Oikawa M, Kakita T, Okada T, Abe T, Yazawa T, et al. The Controlling Nutritional Status (CONUT) Score as a prognostic factor for obstructive colorectal cancer patients received stenting as a bridge to curative surgery. Surg Today. 2021;51(1):144–52.
Comments (0)